Developing Asthma Interventions Using Community Based Research
NCT ID: NCT00728169
Last Updated: 2009-09-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
62 participants
OBSERVATIONAL
2008-07-31
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary goal of this project is to use Community-Based Participatory Research methodology to develop interventions aimed at improving asthma management in high-risk African American asthmatics. This "ground-up" longterm approach has never been tested before in asthmatics. The primary goal of this study will be accomplished with four specific aims:
Aim 1. Conduct focus groups to identify barriers to asthma management in the target population.
Aim 2. Use a community advisory board (CAB) consisting of participants selected from the various focus groups to gather information about solutions for the above barriers.
Aim 3. Use the information from the CAB to develop an intervention to improve asthma self management behaviors in the target population.
Aim 4. Refine the developed intervention based on feedback from focus groups conducted in Aim 1.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Center for Reducing Asthma Disparities - Meharry/Vanderbilt Centers
NCT00281151
Complementary and Alternative Medicine Use in Low-Income African American and Caucasian Adults With Asthma
NCT00094419
Title: Comparative Effectiveness of Asthma Interventions Within an AHRQ PBRN
NCT01280500
Feasibility of an Asthma Online Social Intervention
NCT05829265
Center for Reducing Asthma Disparities - Harvard University/Boston Area Community Health Centers
NCT00281086
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The discussion will last from 1.5 - 2 hours. The focus group discussion will have a maximum of 10 people.
We will be audio and video taping the discussion so that we do not miss any information that volunteers share with us. The audio and video tapes will not be shared with anyone outside our staff.
Volunteer participation in this study is voluntary and there will be no negative consequences if volunteers decide not to participate. Volunteers are also free to withdraw from this study at any time. Withdrawal or refusal to participate will not affect health care services or other rights.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Non-African American
* Non-English speaking
* Do not reside in Davidson County, Tennessee
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Meharry Medical College
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Meharry Medical College
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David S Trochtenberg, MD
Role: PRINCIPAL_INVESTIGATOR
Meharry Medical College
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Meharry Medical College
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
020715JEM13314
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.